International Journal of Radiation Oncology * Biology * Physics
Volume 64, Issue 2 , Pages 382-391 , 1 February 2006

Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma

Presented at the 46th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), October 17–20, 2004, Atlanta, GA.

  • Joseph K. Salama, M.D.

      Affiliations

    • Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL, USA
    • ,
  • Everett E. Vokes, M.D.

      Affiliations

    • Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL, USA
    • Section of Hematology/Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL, USA
    • Cancer Research Center, University of Chicago Pritzker School of Medicine, Chicago, IL, USA
    • ,
  • Steven J. Chmura, M.D., Ph.D.

      Affiliations

    • Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL, USA
    • ,
  • Michael T. Milano, M.D., Ph.D.

      Affiliations

    • Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL, USA
    • ,
  • Johnny Kao, M.D.

      Affiliations

    • Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL, USA
    • ,
  • Kirsten M. Stenson, M.D.

      Affiliations

    • Cancer Research Center, University of Chicago Pritzker School of Medicine, Chicago, IL, USA
    • Section of Otolaryngology/Head and Neck Surgery, University of Chicago Pritzker School of Medicine, Chicago, IL, USA
    • ,
  • Mary Ellyn Witt, R.N.

      Affiliations

    • Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL, USA
    • ,
  • Daniel J. Haraf, M.D.

      Affiliations

    • Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL, USA
    • Cancer Research Center, University of Chicago Pritzker School of Medicine, Chicago, IL, USA
    • Corresponding Author InformationReprint requests to: Daniel J. Haraf, M.D., Department of Radiation and Cellular Oncology, University of Chicago Hospitals, 5758 S. Maryland Ave., MC 9006, Chicago, IL 60637-1470. Tel: (773) 702-5976; Fax: (773) 834-7340

Received 9 March 2005 ,Revised 15 June 2005 ,Accepted 1 July 2005.

References 

  1. Cooper JS , Pajak TF , Forastiere AA , et al.   Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck . N Engl J Med . 2004;350:1937–1944
  2. Bernier J , Domenge C , Ozsahin M , et al.   Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer . N Engl J Med . 2004;350:1945–1952
  3. Forastiere AA , Goepfert H , Maor M , et al.   Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer . N Engl J Med . 2003;349:2091–2098
  4. Forastiere A , Koch W , Trotti A , et al.   Head and neck cancer . N Engl J Med . 2001;345:1890–1900
  5. Brockstein B , Vokes EE . Concurrent chemoradiotherapy for head and neck cancer . Semin Oncol . 2004;31:786–793
  6. McLaughlin MP , Parsons JT , Fein DA , et al.   Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx . Head Neck . 1996;18:229–235
  7. Wong LY , Wei WI , Lam LK , et al.   Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery . Head Neck . 2003;25:953–959
  8. Parsons JT , Mendenhall WM , Stringer SP , et al.   Salvage surgery following radiation failure in squamous cell carcinoma of the supraglottic larynx . Int J Radiat Oncol Biol Phys . 1995;32:605–609
  9. Mabanta SR , Mendenhall WM , Stringer SP , et al.   Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes . Head Neck . 1999;21:591–594
  10. Liverpool Head and Neck Oncology Group . A phase III randomised trial of cisplatinum, methotrexate, cisplatinum + methotrexate, and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck . Br J Cancer . 1990;61:311–315
  11. Stevens KR , Britsch A , Moss WT . High-dose reirradiation of head and neck cancer with curative intent . Int J Radiat Oncol Biol Phys . 1994;29:687–698
  12. Wang CC . Re-irradiation of recurrent nasopharyngeal carcinoma—Treatment techniques and results . Int J Radiat Oncol Biol Phys . 1987;13:953–956
  13. Weichselbaum RR , Beckett MA , Schwartz JL , et al.   Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy . Int J Radiat Oncol Biol Phys . 1988;15:575–579
  14. DeLaney TF , Afridi N , Taghian AG , et al.   13-Cis-retinoic acid with alpha-2a-interferon enhances radiation cytotoxicity in head and neck squamous cell carcinoma in vitro . Cancer Res . 1996;56:2277–2280
  15. Vokes EE , Beckett M , Karrison T , et al.   The interaction of 5-fluorouracil, hydroxyurea, and radiation in two human head and neck cancer cell lines . Oncology . 1992;49:454–460
  16. Hong WK , Bromer R . Chemotherapy in head and neck cancer . N Engl J Med . 1983;308:75–79
  17. Richards GJ , Chambers RG . Hydroxyurea (A radiosensitizer in the treatment of neoplasms of the head and neck) . Am J Roentgenol Radium Ther Nucl Med . 1969;105:555–565
  18. Lo TC , Wiley AL , Ansfield FJ , et al.   Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx (A randomized study) . AJR Am J Roentgenol . 1976;126:229–235
  19. Moran RG , Danenberg PV , Heidelberger C . Therapeutic response of leukemic mice treated with fluorinated pyrimidines and inhibitors of deoxyuridylate synthesis . Biochem Pharmacol . 1982;31:2929–2935
  20. Frankfurt OS . Enhancement of the antitumor activity of 5-fluorouracil by drug combinations . Cancer Res . 1973;33:1043–1047
  21. Vokes EE , Panje WR , Schilsky RL , et al.   Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer (A phase I-II study) . J Clin Oncol . 1989;7:761–768
  22. Haraf DJ , Weichselbaum RR , Vokes EE . Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer (A potentially curable disease) . Ann Oncol . 1996;7:913–918
  23. Brockstein B , Haraf DJ , Stenson K , et al.   Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck . J Clin Oncol . 1998;16:735–744
  24. Vokes EE , Haraf DJ , Mick R , et al.   Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer . J Clin Oncol . 1994;12:2351–2359
  25. Brockstein B , Haraf DJ , Stenson K , et al.   A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer . Ann Oncol . 2000;11:721–728
  26. Chmura SJ , Vokes EE , Garofalo M , et al.   Long-term outcome of re-irradiation with concomitant chemotherapy for locally recurrent squamous cell carcinoma of the head and neck . Int J Radiat Oncol Biol Phys . 2003;57:S409–S410
  27. Salama JK , Haraf DJ , Stenson K , et al.   Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer (Toxicity and outcome results) . Cancer J . 2005;11:140–146
  28. Milano MT , Haraf DJ , Stenson KM , et al.   Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck . Clin Cancer Res . 2004;10:4922–4932
  29. De Crevoisier R , Domenge C , Wibault P , et al.   Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma . Cancer . 2001;91:2071–2076
  30. De Crevoisier R , Bourhis J , Domenge C , et al.   Full-dose reirradiation for unresectable head and neck carcinoma (Experience at the Gustave-Roussy Institute in a series of 169 patients) . J Clin Oncol . 1998;16:3556–3562
  31. Spencer SA , Harris J , Wheeler RH , et al.   RTOG 96-10 (Reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck) . Int J Radiat Oncol Biol Phys . 2001;51:1299–1304
  32. Spencer SA , Wheeler RH , Peters GE , et al.   Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck . Am J Clin Oncol . 1999;22:1–5
  33. Haraf DJ , Vokes EE , Weichselbaum RR , et al.   Concomitant chemoradiotherapy with cisplatin, 5-fluorouracil, and hydroxyurea in poor-prognosis head and neck cancer . Laryngoscope . 1992;102:630–636
  34. Milano MT , Vokes EE , Stenson KM , et al.   Twice-daily re-irradiation of recurrent and second primary head and neck cancer with gemcitabine, paclitaxel, and fluorouracil chemoradiotherapy . J Clin Oncol . 2004;22:
  35. Milano MT , Vokes EE , Salama JK , et al.   Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy . Int J Radiat Oncol Biol Phys . 2005;61:1096–1106
  36. Haraf D , Chung T , Stenson K , et al.   High dose reirradiation with concomitant chemotherapy for local/regionally recurrent head and neck cancer (HNC) (Results in 48 patients) . [Abstract] Proc Am Soc Clin Oncol . 2000;19:413a
  37. Kao J , Garofalo MC , Milano MT , et al.   Reirradiation of recurrent and second primary head and neck malignancies (A comprehensive review) . Cancer Treat Rev . 2003;29:21–30
  38. Machtay M , Rosenthal DI , Chalian AA , et al.   Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer . Int J Radiat Oncol Biol Phys . 2004;59:72–77
  39. Spencer S , Wheeler R , Peters G , et al.   Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer . Head Neck . 2003;25:118–122
  40. Schaefer U , Micke O , Schueller P , et al.   Recurrent head and neck cancer (Retreatment of previously irradiated areas with combined chemotherapy and radiation therapy—Results of a prospective study) . Radiology . 2000;216:371–376
  41. Datta NR , Nagar YS , Singh S , et al.   Loco-regional failures in head and neck cancer (Can they be effectively salvaged by nonsurgical therapeutic modalities?) . Int J Clin Oncol . 2003;8:31–39
  42. Langer CJ . Phase II trial of concurrent split course hyperfractionated radiotherapy (HFX RT), cisplatin (DDP), and paclitaxel (P) in patients with recurrent, previously irradiated squamous cell carcinoma of the head and neck (SCCHN) (Results of RTOG 9911) . J Clin Oncol . 2004;22(Suppl):5509; No. 14S, July 15, 2004
  43. Fu KK , Pajak TF , Trotti A , et al.   A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas (First report of RTOG 9003) . Int J Radiat Oncol Biol Phys . 2000;48:7–16
  44. Maran AG , Amin M , Wilson JA . Radical neck dissection (A 19-year experience) . J Laryngol Otol . 1989;103:760–764

PII: S0360-3016(05)01165-X

doi: 10.1016/j.ijrobp.2005.07.005

International Journal of Radiation Oncology * Biology * Physics
Volume 64, Issue 2 , Pages 382-391 , 1 February 2006

Article Tools

* Image Usage & Resolution